RE: Interview25 Jun 2020 17:44
When talking about further fundraising, he's already explained they're covered for all the existing stuff but says:
"I won't say no to that, and I can't say yes either, so we need to see what the data looks like, how strong it is, and what the follow on activities are".
So if the data is good, the price rockets, they raise cash, and follow on activities could be mega COVID sales, and ramping up the business for COPD etc.
"I think getting this hospital dosed data set in July is going to be such a big event for us".
I think he's pretty excited. Maybe the hospital data is better than I'd hoped.